← All trials
NCT00992901
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2009
- Primary completion
- Jul 1, 2020
- Completion date
- Jul 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 160
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Cedars-Sinai Medical CenterLead sponsor
- Cedars-Sinai Medical CenterOverall official - principal investigator
- Cedars-Sinai Medical CenterReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.